부산대학교 도서관

So J; Department of Radiation Oncology, NYU Grossman School of Medicine, New York, New York. Electronic address: Jonathan.So2@nyulangone.org.; Droznin AD; Department of Radiation Oncology, Dana-Farber Brigham and Women's Cancer Center, Boston, Massachusetts.; Tiwari P; Cancer Program, Broad Institute, Cambridge, Massachusetts.; Chen YH; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Chau NG; Division of Medical Oncology, The University of British Columbia, British Columbia, Canada.; Margalit DN; Department of Radiation Oncology, Dana-Farber Brigham and Women's Cancer Center, Boston, Massachusetts.; Tishler RB; Department of Radiation Oncology, Dana-Farber Brigham and Women's Cancer Center, Boston, Massachusetts.; Hanna GJ; Department of Medical Oncology, Dana-Farber Brigham and Women's Cancer Center, Boston, Massachusetts.; Mak RH; Department of Radiation Oncology, Dana-Farber Brigham and Women's Cancer Center, Boston, Massachusetts.; Fitzgerald KJ; Department of Radiation Oncology, Dana-Farber Brigham and Women's Cancer Center, Boston, Massachusetts.; Sehgal K; Department of Medical Oncology, Dana-Farber Brigham and Women's Cancer Center, Boston, Massachusetts.; Li S; Translational Immunogenomics Lab, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Gunasti L; Department of Radiation Oncology, Dana-Farber Brigham and Women's Cancer Center, Boston, Massachusetts.; Kim E; Department of Radiation Oncology, Dana-Farber Brigham and Women's Cancer Center, Boston, Massachusetts.; Minken J; Department of Radiation Oncology, Dana-Farber Brigham and Women's Cancer Center, Boston, Massachusetts.; Baginska J; Translational Immunogenomics Lab, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Nau A; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Diaz IG; Translational Immunogenomics Lab, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Shim B; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Janes JT 3rd; Translational Immunogenomics Lab, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Uppaluri R; Department of Surgical Oncology, Dana-Farber Brigham and Women's Cancer Center, Boston, Massachusetts.; Haddad RI; Department of Medical Oncology, Dana-Farber Brigham and Women's Cancer Center, Boston, Massachusetts.; Livak KJ; Translational Immunogenomics Lab, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Schoenfeld JD; Department of Radiation Oncology, Dana-Farber Brigham and Women's Cancer Center, Boston, Massachusetts. Electronic address: jdschoenfeld@partners.org.

Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

Sun H; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Sklavenitis Pistofidis R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA, United States.; Liu S; Dana Farber Cancer Institute, Boston, Massachusetts, United States.; Liu X; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Tsakmaklis N; Dana Farber Cancer Institute, Boston, Massachusetts, United States.; Hatcher JM; Dana-Farber Cancer Institute, Royal Palm Beach, Florida, United States.; Guerrera ML; Dana Farber Cancer Institute, Boston, Massachusetts, United States.; Kofides A; Dana Farber Cancer Institute, Boston, Massachusetts, United States.; Ramirez-Gamero AF; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.; Peachey A; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Li S; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Keskin D; DFCI HArvard, Boston, Massachusetts, United States.; Chea V; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Kim N; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Lyu H; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Lu W; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Livak KJ; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Meid KE; Dana Farber Cancer Institute, Boston, Massachusetts, United States.; Guijosa A; Dana Farber Cancer-Institute, Boston, Massachusetts, United States.; Flynn C; Dana Farber Cancer Institute, Boston, Massachusetts, United States.; Pizzarella D; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Patterson CJ; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Hao M; Blood hospital and hematology institute, state key lab of experimental hematology, Tianjin, China.; Yi S; Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking, Tianjin, China.; Yuan W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Branagan AR; Massachusetts General Hospital, Boston, Massachusetts, United States.; Wu CJ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States.; Ghobrial IM; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Qiu L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Disorders, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China.; Sarosiek S; Dana Farber Cancer Institute, Boston, Massachusetts, United States.; Castillo JJ; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Hunter ZR; Dana Farber Cancer Institute, Boston, Massachusetts, United States.; Treon SP; Dana Farber Cancer Institute, Boston, Massachusetts, United States.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Penter L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Hematology, Oncology, and Cancer Immunology, Campus Virchow-Klinikum, Berlin, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health Charité Digital Clinician Scientist Program, Berlin Institute of Health Biomedical Innovation Academy, Berlin Institute of Health at Charité Universitätsmedizin Berlin, Berlin, Germany.; Maurer K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA.; Harvard Medical School, Boston, MA.; Cieri N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA.; Harvard Medical School, Boston, MA.; Lu WS; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA.; Lyu H; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA.; Selig M; Department of Hematology, Oncology, and Cancer Immunology, Campus Virchow-Klinikum, Berlin, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Joosten M; Institute of Pathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Ihlow J; Berlin Institute of Health Charité Digital Clinician Scientist Program, Berlin Institute of Health Biomedical Innovation Academy, Berlin Institute of Health at Charité Universitätsmedizin Berlin, Berlin, Germany.; Institute of Pathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Li S; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA.; Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA.; Bullinger L; Department of Hematology, Oncology, and Cancer Immunology, Campus Virchow-Klinikum, Berlin, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Bachireddy P; MD Anderson Cancer Center, Houston, TX.; Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA.; Harvard Medical School, Boston, MA.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Maurer K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Harvard Medical School, Boston, MA 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Park CY; Irving Institute for Cancer Dynamics, Columbia University, New York, NY 10027, USA.; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.; Mani S; Irving Institute for Cancer Dynamics, Columbia University, New York, NY 10027, USA.; Department of Computer Science, Columbia University, New York, NY 10027, USA.; Borji M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Raths F; Singular Genomics, San Diego, CA 92121, USA.; Gouin KH 3rd; Singular Genomics, San Diego, CA 92121, USA.; Penter L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Harvard Medical School, Boston, MA 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Berlin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 13353 Berlin, Germany.; Jin Y; Irving Institute for Cancer Dynamics, Columbia University, New York, NY 10027, USA.; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.; Zhang JY; Irving Institute for Cancer Dynamics, Columbia University, New York, NY 10027, USA.; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.; Shin C; Irving Institute for Cancer Dynamics, Columbia University, New York, NY 10027, USA.; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.; Brenner JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Harvard Medical School, Boston, MA 02115, USA.; Southard J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Krishna S; Spatial Technology Platform, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Lu W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Lyu H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Abbondanza D; Spatial Technology Platform, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.; Mangum C; Spatial Technology Platform, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Olsen LR; Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.; Lawson MJ; Singular Genomics, San Diego, CA 92121, USA.; Fabani M; Singular Genomics, San Diego, CA 92121, USA.; Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Bachireddy P; Department of Hematopoietic Biology & Malignancy, MD Anderson Cancer Center, Houston, TX 77030, USA.; Glezer EN; Singular Genomics, San Diego, CA 92121, USA.; Farhi SL; Spatial Technology Platform, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Li S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Harvard Medical School, Boston, MA 02115, USA.; Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Harvard Medical School, Boston, MA 02115, USA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Harvard Medical School, Boston, MA 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Azizi E; Irving Institute for Cancer Dynamics, Columbia University, New York, NY 10027, USA.; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.; Department of Computer Science, Columbia University, New York, NY 10027, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9468 (Electronic) Linking ISSN: 24709468 NLM ISO Abbreviation: Sci Immunol Subsets: MEDLINE

Treon SP; Dana-Farber Cancer Institute, Boston, MA, United States.; Kotton CN; Massachusetts General Hospital, Boston, MA, United States.; Park DJ; Providence St. Jude Medical Center/Providence Medical Foundation, Fullerton, CA, United States.; Moranzoni G; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Lemvigh CK; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Gathe JC Jr; Therapeutic Concepts, PA, Houston, TX, United States.; Varughese TA; Rutgers New Jersey Medical School, Newark, NJ, United States.; Barnett CF; MedStar Washington Hospital Center, Washington, DC, United States.; Belenchia JM; Archbold Medical Center, Thomasville, GA, United States.; Clark NM; Loyola University Stritch School of Medicine, Chicago, IL, United States.; Farber CM; Atlantic Health System, Morristown, NJ, United States.; Abid MB; Medical College of Wisconsin, Milwaukee, WI, United States.; Ahmed G; Medical College of Wisconsin, Milwaukee, WI, United States.; Patterson CJ; Dana-Farber Cancer Institute, Boston, MA, United States.; Guerrera ML; Dana-Farber Cancer Institute, Boston, MA, United States.; Soumerai JD; Massachusetts General Hospital, Boston, MA, United States.; Chea VA; Dana-Farber Cancer Institute, Boston, MA, United States.; Carulli IP; Dana-Farber Cancer Institute, Boston, MA, United States.; Southard J; Dana-Farber Cancer Institute, Boston, MA, United States.; Li S; Dana-Farber Cancer Institute, Boston, MA, United States.; Wu CJ; Dana-Farber Cancer Institute, Boston, MA, United States.; Livak KJ; Dana-Farber Cancer Institute, Boston, MA, United States.; Holmgren E; BeiGene USA, Inc., San Mateo, CA, United States.; Kim P; BeiGene USA, Inc., San Mateo, CA, United States.; Shi C; BeiGene USA, Inc., San Mateo, CA, United States.; Lin H; BeiGene USA, Inc., San Mateo, CA, United States.; Ramakrishnan V; BeiGene USA, Inc., San Mateo, CA, United States.; Ou Y; BeiGene USA, Inc., San Mateo, CA, United States.; Olszewski S; BeiGene USA, Inc., San Mateo, CA, United States.; Olsen LR; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Keskin DB; Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Hunter ZR; Dana-Farber Cancer Institute, Boston, MA, United States.; Tankersley C; BeiGene USA, Inc., San Mateo, CA, United States.; Zimmerman T; BeiGene USA, Inc., San Mateo, CA, United States.; Dhakal B; Medical College of Wisconsin, Wauwatosa, WI, United States.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Sariipek NE; Safina KR; Lu WS; Li S; Janes JT; Orden MV; Livak KJ; Heaton H; Ho VT; Koreth J; Luskin MR; Griffin GK; Garcia JS; Lindsley RC; Cutler C; Soiffer RJ; Ritz J; Wu CJ; Antin JH; Lane AA; Gooptu M; van Galen P

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Walker MA; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Howard Hughes Medical Institute and the Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Li S; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Karaa A; Department of Pediatrics, Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.; Wu CJ; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Mootha VK; Howard Hughes Medical Institute and the Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA.

Publisher: Wiley Country of Publication: United States NLM ID: 7910918 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2665 (Electronic) Linking ISSN: 01418955 NLM ISO Abbreviation: J Inherit Metab Dis Subsets: MEDLINE

Blass E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.; Keskin DB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Harvard Medical School, Boston, MA 02215, USA; Department of Computer Science, Metropolitan College, Boston University, Boston, MA 02215, USA; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, 2800 Lyngby, Denmark.; Tu CR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Forman C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Vanasse A; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Sax HE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Shim B; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Chea V; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Kim N; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Carulli I; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Southard J; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Lyu H; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Lu W; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Rickles-Young M; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Afeyan AB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.; Olive O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Mehndiratta A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Greenslade H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Shetty K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Baginska J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Gomez Diaz I; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Nau A; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Pfaff KL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Gans A; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Ranasinghe S; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Buchbinder EI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02215, USA.; Sussman TA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02215, USA.; Insco ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02215, USA.; Yoon CH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA; Department of Surgery, Brigham and Women's Hospital, Boston, MA 02215, USA.; Rodig SJ; Harvard Medical School, Boston, MA 02215, USA; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02215, USA.; Shukla SA; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Li S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Aster JC; Harvard Medical School, Boston, MA 02215, USA; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02215, USA.; Braun DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06511, USA; Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT 06511, USA.; Cibulskis C; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Hacohen N; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Harvard Medical School, Boston, MA 02215, USA; Massachusetts General Hospital, Krantz Family Center for Cancer Research, Boston, MA 02114, USA.; Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Giobbie-Hurder A; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Livak KJ; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Fritsch EF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Oliveira G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Harvard Medical School, Boston, MA 02215, USA.; Simon JM; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02215, USA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Harvard Medical School, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02215, USA.; Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Harvard Medical School, Boston, MA 02215, USA; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02215, USA. Electronic address: patrick_ott@dfci.harvard.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE

Huang X; F.M. Kirby Neurobiology Research Center, Boston Children's Hospital, Boston, MA 02115, USA.; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.; Lee S; F.M. Kirby Neurobiology Research Center, Boston Children's Hospital, Boston, MA 02115, USA.; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.; Chen K; F.M. Kirby Neurobiology Research Center, Boston Children's Hospital, Boston, MA 02115, USA.; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.; Kawaguchi R; Department of Psychiatry and Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.; Wiskow O; Department of Stem Cell and Regenerative Biology and Department of Molecular and Cellular Biology, Harvard Stem Cell Institute, Cambridge, MA 02138, USA.; Ghosh S; Department of Stem Cell and Regenerative Biology and Department of Molecular and Cellular Biology, Harvard Stem Cell Institute, Cambridge, MA 02138, USA.; Frost D; F.M. Kirby Neurobiology Research Center, Boston Children's Hospital, Boston, MA 02115, USA.; Perrault L; F.M. Kirby Neurobiology Research Center, Boston Children's Hospital, Boston, MA 02115, USA.; Pandey R; F.M. Kirby Neurobiology Research Center, Boston Children's Hospital, Boston, MA 02115, USA.; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.; Klim JR; Department of Stem Cell and Regenerative Biology and Department of Molecular and Cellular Biology, Harvard Stem Cell Institute, Cambridge, MA 02138, USA.; Boivin B; F.M. Kirby Neurobiology Research Center, Boston Children's Hospital, Boston, MA 02115, USA.; Hermawan C; F.M. Kirby Neurobiology Research Center, Boston Children's Hospital, Boston, MA 02115, USA.; Livak KJ; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Geschwind DH; Department of Psychiatry and Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.; Wainger BJ; Department of Neurology, Mass General Brigham and Harvard Medical School, Boston, MA 02114, USA.; Eggan KC; Department of Stem Cell and Regenerative Biology and Department of Molecular and Cellular Biology, Harvard Stem Cell Institute, Cambridge, MA 02138, USA.; Bean BP; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.; Woolf CJ; F.M. Kirby Neurobiology Research Center, Boston Children's Hospital, Boston, MA 02115, USA.; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 101755125 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-1297 (Electronic) Linking ISSN: 26321297 NLM ISO Abbreviation: Brain Commun Subsets: PubMed not MEDLINE

Penter L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Digital Clinician Scientist Program, Charitéplatz 1, 10117, Berlin, Germany.; Borji M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Nagler A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Lyu H; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Lu WS; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Cieri N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Maurer K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Oliveira G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Al'Khafaji AM; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Garimella KV; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Li S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. catherine_wu@dfci.harvard.edu.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA. catherine_wu@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. catherine_wu@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. catherine_wu@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

McCurry D; Ge Z; Lee J; Pasumarthi R; Leng X; Koehnke T; Pasvolsky O; Raparla P; Nguyen V; Maurer K; Li S; Livak KJ; Danson E; Thakkar B; Azizi E; Soiffer RJ; Shukla SA; Majeti R; Ritz J; Wu CJ; Molldrem JJ; Bachireddy P

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Cieri N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Hookeri N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Stromhaug K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Li L; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Keating J; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Díaz-Fernández P; Department of Immunology, Instituto de Investigación Sanitaria Princesa (IIS-IP), Hospital Universitario de La Princesa, Madrid, Spain.; Gómez-García de Soria V; Department of Hematology, Instituto de Investigación Sanitaria Princesa (IIS-IP), Hospital Universitario de La Princesa, Madrid, Spain.; Stevens J; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Kfuri-Rubens R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Shao Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Kooshesh KA; Harvard Medical School, Boston, MA, USA.; Powell K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Ji H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Hernandez GM; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Abelin J; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Klaeger S; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Department of Proteomic and Genomic Technologies, Genentech Inc, South San Francisco, CA, USA.; Forman C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Clauser KR; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Sarkizova S; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Braun DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.; Penter L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Berlin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Kim HT; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Lane WJ; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Oliveira G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Kean LS; Harvard Medical School, Boston, MA, USA.; Division Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Li S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Carr SA; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Keskin DB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Computer Science, Metropolitan College, Boston University, Boston, MA, USA.; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.; Muñoz-Calleja C; Department of Immunology, Instituto de Investigación Sanitaria Princesa (IIS-IP), Hospital Universitario de La Princesa, Madrid, Spain.; Department of Medicine, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.; Ho VT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Stewart C; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Getz G; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. catherine_wu@dfci.harvard.edu.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA. catherine_wu@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. catherine_wu@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. catherine_wu@dfci.harvard.edu.

Publisher: Nature America Publishing Country of Publication: United States NLM ID: 9604648 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1696 (Electronic) Linking ISSN: 10870156 NLM ISO Abbreviation: Nat Biotechnol Subsets: MEDLINE

Braun DA; Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA. david.braun@yale.edu.; Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA. david.braun@yale.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. david.braun@yale.edu.; Moranzoni G; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Chea V; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; McGregor BA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Blass E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Tu CR; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Vanasse AP; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Forman C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Forman J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Afeyan AB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Schindler NR; Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.; Liu Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Li S; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Southard J; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Chang SL; Harvard Medical School, Boston, MA, USA.; Department of Urology, Brigham and Women's Hospital, Boston, MA, USA.; Hirsch MS; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; LeBoeuf NR; Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Brigham and Women's Cancer Center, Boston, MA, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Olive O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Mehndiratta A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Greenslade H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Shetty K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Klaeger S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Sarkizova S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Pedersen CB; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Center for Genomic Medicine, Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark.; Mossanen M; Harvard Medical School, Boston, MA, USA.; Department of Urology, Brigham and Women's Hospital, Boston, MA, USA.; Carulli I; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Tarren A; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Duke-Cohan J; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Howard AA; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Iorgulescu JB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Molecular Diagnostics Laboratory, Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Shim B; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Simon JM; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Signoretti S; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Aster JC; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Elagina L; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Carr SA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Leshchiner I; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Section of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, USA.; Getz G; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Gabriel S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Hacohen N; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Olsen LR; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Oliveira G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Livak KJ; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Shukla SA; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fritsch EF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. catherine_wu@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. catherine_wu@dfci.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. catherine_wu@dfci.harvard.edu.; Keskin DB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Computer Science, Metropolitan College, Boston University, Boston, MA, USA.; Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. toni_choueiri@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. toni_choueiri@dfci.harvard.edu.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Yeo YY; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.; Program in Virology, Division of Medical Sciences, Harvard Medical School, Boston, MA, United States.; Chang Y; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, OH, United States.; Department of Biomedical Informatics, College of Medicine, Ohio State University, Columbus, OH, United States.; Qiu H; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.; Yiu SPT; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.; Michel HA; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.; Program in Virology, Division of Medical Sciences, Harvard Medical School, Boston, MA, United States.; Wu W; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.; Jin X; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, OH, United States.; Department of Biomedical Informatics, College of Medicine, Ohio State University, Columbus, OH, United States.; Kure S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Parmelee L; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.; Luo S; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.; Cramer P; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.; Lee JL; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.; Wang Y; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.; Yeung J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.; Ahmar NE; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.; Simsek B; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.; Mohanna R; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.; Van Orden M; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Lu W; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Livak KJ; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Li S; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Shahryari J; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Kingsley L; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Al-Humadi RN; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Nasr S; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Nkosi D; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.; Sadigh S; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.; Rock P; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, United States.; Frauenfeld L; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.; Kaufmann L; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.; Zhu B; Broad Institute of Harvard and MIT, Cambridge, MA, United States.; Basak A; Broad Institute of Harvard and MIT, Cambridge, MA, United States.; Dhanikonda N; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.; Chan CN; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.; Krull J; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, OH, United States.; Department of Biomedical Informatics, College of Medicine, Ohio State University, Columbus, OH, United States.; Cho YW; Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, MA, United States.; Chen CY; Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, MA, United States.; Lee JYJ; Bioinformatics Institute (BII), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.; Wang H; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.; Zhao B; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.; Loo LH; Bioinformatics Institute (BII), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.; Kim DM; Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, MA, United States.; Boussiotis V; Department of Hematology Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.; Zhang B; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Shalek AK; Broad Institute of Harvard and MIT, Cambridge, MA, United States.; Howitt B; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Signoretti S; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.; Schürch CM; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.; Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Burack WR; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, United States.; Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.; Ma Q; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, OH, United States.; Department of Biomedical Informatics, College of Medicine, Ohio State University, Columbus, OH, United States.; Jiang S; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.; Program in Virology, Division of Medical Sciences, Harvard Medical School, Boston, MA, United States.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.; Broad Institute of Harvard and MIT, Cambridge, MA, United States.; Department of Pathology, Dana Farber Cancer Institute, Boston, MA, United States.

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Maurer K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.; Grabski IN; Department of Biostatistics, Harvard University, Boston, MA.; Houot R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Hematology, University Hospital of Rennes, UMR U1236, INSERM, University of Rennes, Rennes, France.; Gohil SH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Haematology, University College London, London, United Kingdom.; Department of Haematology, University College London Hospitals National Health Service Foundation Trust, London, United Kingdom.; Miura S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Redd R; Department of Biostatistics, Harvard University, Boston, MA.; Lyu H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA.; Lu W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA.; Arihara Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Budka J; Kite, a Gilead Company, Santa Monica, CA.; McDonough M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Ansuinelli M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Reynolds C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Jacene H; Harvard Medical School, Boston, MA.; Department of Imaging, Dana-Farber Cancer Institute, Boston, MA.; Li S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA.; Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA.; Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Miles B; Kite, a Gilead Company, Santa Monica, CA.; Mattie M; Kite, a Gilead Company, Santa Monica, CA.; Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Irizarry RA; Department of Biostatistics, Harvard University, Boston, MA.; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.; Jacobson C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Penter L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Digital Clinician Scientist Program, Berlin, Germany.; Cieri N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Maurer K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Kwok M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Lyu H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lu WS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts.; Oliveira G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Gohil SH; Department of Haematology, University College London Hospitals, London, United Kingdom.; Leshchiner I; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.; Lareau CA; Memorial Sloan Kettering Cancer Center, New York City, New York.; Ludwig LS; Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health at Charité Universitätsmedizin Berlin, Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin Institute for Medical Systems Biology, Berlin, Germany.; Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Kim HT; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Li S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts.; Bullinger L; Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Getz G; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE

Park C; Department of Biomedical Engineering, Columbia University, New York, New York 10027, USA; cyp2111@columbia.edu ea2690@columbia.edu.; Irving Institute for Cancer Dynamics, Columbia University, New York, New York 10027, USA.; Mani S; Irving Institute for Cancer Dynamics, Columbia University, New York, New York 10027, USA.; Department of Computer Science, Columbia University, New York, New York 10027, USA.; Beltran-Velez N; Department of Computer Science, Columbia University, New York, New York 10027, USA.; Maurer K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.; Harvard Medical School, Boston, Massachusetts 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA.; Huang T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.; Li S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.; Gohil S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.; Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.; Knowles DA; Department of Computer Science, Columbia University, New York, New York 10027, USA.; Data Science Institute, Columbia University, New York, New York 10027, USA.; New York Genome Center, New York, New York 10013, USA.; Department of Systems Biology, Columbia University, New York, New York 10032, USA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.; Harvard Medical School, Boston, Massachusetts 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA.; Azizi E; Department of Biomedical Engineering, Columbia University, New York, New York 10027, USA; cyp2111@columbia.edu ea2690@columbia.edu.; Irving Institute for Cancer Dynamics, Columbia University, New York, New York 10027, USA.; Department of Computer Science, Columbia University, New York, New York 10027, USA.; Data Science Institute, Columbia University, New York, New York 10027, USA.

Publisher: Cold Spring Harbor Laboratory Press Country of Publication: United States NLM ID: 9518021 Publication Model: Electronic Cited Medium: Internet ISSN: 1549-5469 (Electronic) Linking ISSN: 10889051 NLM ISO Abbreviation: Genome Res Subsets: MEDLINE

Muñoz, José F.; Gauthier, Gregory M.; Desjardins, Christopher A.; Gallo, Juan E.; Holder, Jason; Sullivan, Thomas D.; Marty, Amber J.; Carmen, John C.; Chen, Zehua; Ding, Li; Gujja, Sharvari; Magrini, Vincent; Misas, Elizabeth; Mitreva, Makedonka; Priest, Margaret; Saif, Sakina; Whiston, Emily A.; Young, Sarah; Zeng, Qiandong; Goldman, William E.; Mardis, Elaine R.; Taylor, John W.; McEwen, Juan G.; Clay, Oliver K.; Klein, Bruce S.; Cuomo, Christina A.; Pfaller, MA; Diekema, DJ; Meece, JK; Anderson, JL; Fisher, MC; Henk, DA; Sloss, BL; Reed, KD; Brown, EM; McTaggart, LR; Zhang, SX; Low, DE; Stevens, DA; Richardson, SE; Schwarz, J; Baum, GL; Gauthier, G; Klein, BS; Gauthier, GM; Safdar, N; Andes, DR; Pfister, JR; Archer, JR; Hersil, S; Boers, T; Tebbets, B; Marr, KA; Patterson, T; Denning, D; Wisplinghoff, H; Bischoff, T; Tallent, SM; Seifert, H; Wenzel, RP; Edmond, MB; Park, BJ; Wannemuehler, KA; Marston, BJ; Govender, N; Pappas, PG; Chiller, TM; Nemecek, JC; Wuthrich, M; Brandhorst, TT; Roy, R; Wüthrich, M; Nanjappa, S; Filutowicz, H; Galles, K; Warner, T; Klein, B; Burg, EF; Smith, LH; England, DM; Hochholzer, L; Kenyon, C; Bonorchis, K; Corcoran, C; Meintjes, G; Locketz, M; Lehloenya, R; Anstead, GM; Sutton, DA; Graybill, JR; Peterson, SW; Sigler, L; Untereiner, WA; Scott, JA; Naveau, FA; Bachewich, J; Angus, A; Baumgardner, DJ; Paretsky, DP; Sullivan, TD; Rooney, PJ; Li, W; Walton, E; Averette, AF; Sakthikumar, S; Cuomo, CA; Krajaejun, T; Warner, TF; Stamatakis, A; Salichos, L; Rokas, A; Bawdon, RE; Garrison, RG; Fina, LR; Rouxel, T; Grandaubert, J; Hane, JK; Hoede, C; Wouw, AP van de; Couloux, A; Desjardins, CA; Champion, MD; Holder, JW; Muszewska, A; Goldberg, J; Bailao, AM; Kapitonov, VV; Jurka, J; Daboussi, MJ; Capy, P; Hoffman-Sommer, M; Grynberg, M; McEwen, JG; Ortiz, BL; García, AM; Florez, AM; Botero, S; Restrepo, A; Yuen, KY; Chan, CM; Chan, KM; Woo, PC; Che, XY; Leung, AS; Gallardo, SS; Wymelenberg, AJ Vanden; Esteban, PF; Ríos, I; García, R; Dueñas, E; Plá, J; Sánchez, M; Beyhan, S; Gutierrez, M; Voorhies, M; Sil, A; Nguyen, VQ; Webster, RH; Boyce, KJ; Schreider, L; Kirszenblat, L; Andrianopoulos, A; Weissman, Z; Kornitzer, D; Sentandreu, M; Elorza, MV; Sentandreu, R; Fonzi, WA; Lamb, TM; Xu, W; Diamond, A; Mitchell, AP; Citiulo, F; Jacobsen, ID; Miramón, P; Schild, L; Brunke, S; Zipfel, P; Schmaler-Ripcke, J; Sugareva, V; Gebhardt, P; Winkler, R; Kniemeyer, O; Heinekamp, T; Boguslawski, G; Akagi, JM; Ward, LG; Howard, DH; Dabrowa, N; Otto, V; Rhodes, J; Hennicke, F; Grumbt, M; Lermann, U; Ueberschaar, N; Palige, K; Böttcher, B; Herr, RA; Tarcha, EJ; Taborda, PR; Taylor, JW; Ajello, L; Mendoza, L; Gori, S; Drouhet, E; Gueho, E; Huerre, M; Lofaro, A; Parenti, M; Ho, E Gu; Provost, F; Borgers, M; Lander, ES; Linton, LM; Birren, B; Nusbaum, C; Zody, MC; Baldwin, J; Costantini, M; Clay, O; Auletta, F; Bernardi, G; Pavlícek, A; Paces, J; Sharpton, TJ; Stajich, JE; Rounsley, SD; Gardner, MJ; Wortman, JR; Jordar, VS; Martinez, DA; Oliver, BG; Gräser, Y; Goldberg, JM; Martinez-Rossi, NM; Tavares, AHFP; Silva, SS; Dantas, A; Campos, EG; Andrade, RV; Maranhão, AQ; Isaac, DT; Coady, A; Prooyen, N Van; Sugar, AM; Chahal, RS; Brummer, E; Morrison, CJ; Youseff, BH; Holbrook, ED; Smolnycki, KA; Rappleye, CA; McLauchlan, A; Nunes, LR; Oliveira, R Costa de; Leite, DB; Silva, VS da; Marques, E dos Reis; Ferreira, ME da Silva; Monod, M; Yamada, T; Hertweck, C; Kunert, J; Staib, P; Uyttenhove, C; Pilotte, L; Théate, I; Stroobant, V; Colau, D; Parmentier, N; Luca, A De; Carvalho, A; Cunha, C; Iannitti, RG; Pitzurra, L; Giovannini, G; Hage, CA; Horan, DJ; Durkin, M; Connolly, P; Desta, Z; Skaar, TC; Araújo, EF; Loures, FV; Bazan, SB; Feriotti, C; Pina, A; Schanoski, AS; Singh, A; Panting, RJ; Varma, A; Saijo, T; Waldron, KJ; Jong, A; Mirbod-Donovan, F; Schaller, R; Hung, C-Y; Xue, J; Reichard, U; Cole, GT; Jaffe, DB; Butler, J; Gnerre, S; Mauceli, E; Lindblad-Toh, K; Mesirov, JP; Luo, R; Liu, B; Xie, Y; Li, Z; Huang, W; Yuan, J; Simpson, JT; Wong, K; Jackman, SD; Schein, JE; Jones, SJM; Birol, I; Zerbino, DR; Birney, E; Sambrook, J; Russell, DW; Filutowicz, HI; Marty, AJ; Carmen, JC; Worsham, PL; Goldman, WE; Parkhomchuk, D; Borodina, T; Amstislavskiy, V; Banaru, M; Hallen, L; Krobitsch, S; Levin, JZ; Yassour, M; Adiconis, X; Thompson, DA; Friedman, N; Grabherr, MG; Haas, BJ; Amit, I; Salzberg, SL; Zhu, W; Pertea, M; Allen, JE; Orvis, J; Zeng, Q; Pearson, MD; Langmead, B; Trapnell, C; Pop, M; Li, B; Dewey, CN; Robinson, MD; McCarthy, DJ; Smyth, GK; Papanicolaou, A; Grabherr, M; Blood, PD; Bowden, J; Conesa, A; Gotz, S; Garcia-Gomez, JM; Terol, J; Talon, M; Robles, M; Livak, KJ; Schmittgen, TD; Oliver, JL; Carpena, P; Hackenberg, M; Bernaola-Galván, P; Delcher, AL; Pavlicek, A; Klonowski, P; Kohany, O; Walichiewicz, J; Eddy, SR; Rice, P; Longden, I; Bleasby, A; Katoh, K; Toh, H; Price, MN; Dehal, PS; Arkin, AP; Letunic, I; Bork, P; Yang, Z; Griggs, AD; Smith, JL; Blin, K; Medema, MH; Kazempour, D; Fischbach, MA; Breitling, R; Takano, E; Li, L; Stoeckert, CJ; Roos, DS; Storey, JD; Tibshirani, R; Haridas, Sajeet

Maurer K; Park CY; Mani S; Borji M; Penter L; Jin Y; Zhang JY; Shin C; Brenner JR; Southard J; Krishna S; Lu W; Lyu H; Abbondanza D; Mangum C; Olsen LR; Neuberg DS; Bachireddy P; Farhi SL; Li S; Livak KJ; Ritz J; Soiffer RJ; Wu CJ; Azizi E

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Marcucci, G; Livak, KJ; Bi, W; Strout, MP; Bloomfield, CD; Caligiuri, MA

Leukemia. 12(9):1482-1489